_id
6919e4f23c536f8df23180d4
Ticker
BELL.LSE
Name
Belluscura Plc
Exchange
LSE
Address
15 Fetter Lane, London, United Kingdom, EC4A 1BW
Country
UK
Sector
Healthcare
Industry
Medical Devices
Currency
GBX
Website
https://www.belluscura.com
Description
Belluscura plc develops and commercialize oxygen related medical device products in the United States. The company offers X-PLOR and DISCOV-R, a modular portable oxygen concentrator; and related accessories. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.
Last Close
0.0075
Volume
-
Current Price
0.0075
Change
-0.7425
Last Updated
2025-11-26T08:36:08.773Z
Image
https://logo.clearbit.com/www.belluscura.com
Ipo Date
-
Market Cap
3009822
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2024-06-30
Revenue
1345758
Cost Of Revenue
872852
Gross Profit
472906
Operating Expenses
6500130
Operating Income
-6027224
Interest Expense
-
Pretax Income
-6505656
Net Income
-6505656
Eps
-0.04099093471506341
Dividends Per Share
-
Shares Outstanding
401309607
Income Tax Expense
-
EBITDA
-5992834
Operating Margin
-447.8683388841084
Total Other Income Expense Net
-478432
Cash
875670
Short Term Investments
-
Receivables
5166562
Inventories
3365107
Total Current Assets
9407339
Property Plant Equipment
260548
Total Assets
21494528
Payables
2891747
Short Term Debt
-
Long Term Debt
-
Total Liabilities
2926653
Equity
18567875
Depreciation
889660
Change In Working Capital
-515972
Cash From Operations
-5470390
Capital Expenditures
28510
Cash From Investing
-1689836
Cash From Financing
7107338
Net Change In Cash
875670
PE
-
PB
0.06410653938590172
ROE
-35.03715961034852
ROA
-30.266568309850765
FCF
-5498900
Fcf Percent
-4.086098689363169
Piotroski FScore
1
Health Score
34
Deep Value Investing Score
5.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
4.5
Growth Investing Score
3
Momentum Investing Score
2
Net Net Investing Score
7
Quality Investing Score
2.5
Value Investing Score
6.5
Quarters > 0 > quarter
2024-06-30
Quarters > 0 > income Statement > revenue
1345758
Quarters > 0 > income Statement > cost Of Revenue
872852
Quarters > 0 > income Statement > gross Profit
472906
Quarters > 0 > income Statement > operating Expenses
6500130
Quarters > 0 > income Statement > operating Income
-6027224
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-6505656
Quarters > 0 > income Statement > net Income
-6505656
Quarters > 0 > income Statement > eps
-0.04099093471506341
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
158709628
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-5992834
Quarters > 0 > income Statement > operating Margin
-447.8683388841084
Quarters > 0 > income Statement > total Other Income Expense Net
-478432
Quarters > 0 > balance Sheet > cash
875670
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
5166562
Quarters > 0 > balance Sheet > inventories
3365107
Quarters > 0 > balance Sheet > total Current Assets
9407339
Quarters > 0 > balance Sheet > property Plant Equipment
260548
Quarters > 0 > balance Sheet > total Assets
21494528
Quarters > 0 > balance Sheet > payables
2891747
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2926653
Quarters > 0 > balance Sheet > equity
18567875
Quarters > 0 > cash Flow > net Income
-6505656
Quarters > 0 > cash Flow > depreciation
889660
Quarters > 0 > cash Flow > change In Working Capital
-515972
Quarters > 0 > cash Flow > cash From Operations
-5470390
Quarters > 0 > cash Flow > capital Expenditures
28510
Quarters > 0 > cash Flow > cash From Investing
-1689836
Quarters > 0 > cash Flow > cash From Financing
7107338
Quarters > 0 > cash Flow > net Change In Cash
875670
Quarters > 0 > ratios > PE
-0.04099093471506341
Quarters > 0 > ratios > PB
0.06410653938590172
Quarters > 0 > ratios > ROE
-35.03715961034852
Quarters > 0 > ratios > ROA
-30.266568309850765
Quarters > 0 > ratios > FCF
-5498900
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-4.086098689363169
Quarters > 0 > health Score
34
Quarters > 1 > quarter
2024-03-31
Quarters > 1 > income Statement > revenue
672879
Quarters > 1 > income Statement > cost Of Revenue
436426
Quarters > 1 > income Statement > gross Profit
236453
Quarters > 1 > income Statement > operating Expenses
3250065
Quarters > 1 > income Statement > operating Income
-3013612
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-3252828
Quarters > 1 > income Statement > net Income
-3252828
Quarters > 1 > income Statement > eps
-0.020495467357531705
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
158709628
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-2996417
Quarters > 1 > income Statement > operating Margin
-447.8683388841084
Quarters > 1 > income Statement > total Other Income Expense Net
-239216
Quarters > 1 > balance Sheet > cash
875670
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
5166562
Quarters > 1 > balance Sheet > inventories
3365107
Quarters > 1 > balance Sheet > total Current Assets
9407339
Quarters > 1 > balance Sheet > property Plant Equipment
260548
Quarters > 1 > balance Sheet > total Assets
21494528
Quarters > 1 > balance Sheet > payables
2891747
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
2926653
Quarters > 1 > balance Sheet > equity
18567875
Quarters > 1 > cash Flow > net Income
-3252828
Quarters > 1 > cash Flow > depreciation
444830
Quarters > 1 > cash Flow > change In Working Capital
-257986
Quarters > 1 > cash Flow > cash From Operations
-2735195
Quarters > 1 > cash Flow > capital Expenditures
14255
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
3553669
Quarters > 1 > cash Flow > net Change In Cash
-28628
Quarters > 1 > ratios > PE
-0.020495467357531705
Quarters > 1 > ratios > PB
0.06410653938590172
Quarters > 1 > ratios > ROE
-17.51857980517426
Quarters > 1 > ratios > ROA
-15.133284154925382
Quarters > 1 > ratios > FCF
-2749450
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-4.086098689363169
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2023-12-31
Quarters > 2 > income Statement > revenue
459188
Quarters > 2 > income Statement > cost Of Revenue
4606534
Quarters > 2 > income Statement > gross Profit
-4147346
Quarters > 2 > income Statement > operating Expenses
7351506
Quarters > 2 > income Statement > operating Income
-11498852
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-12098488
Quarters > 2 > income Statement > net Income
-12098488
Quarters > 2 > income Statement > eps
-0.08858558405752251
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
136574005
Quarters > 2 > income Statement > income Tax Expense
574454
Quarters > 2 > income Statement > EBITDA
-10905088
Quarters > 2 > income Statement > operating Margin
-2504.170840701412
Quarters > 2 > income Statement > total Other Income Expense Net
-599636
Quarters > 2 > balance Sheet > cash
932926
Quarters > 2 > balance Sheet > short Term Investments
1207711
Quarters > 2 > balance Sheet > receivables
1307508
Quarters > 2 > balance Sheet > inventories
3320652
Quarters > 2 > balance Sheet > total Current Assets
8560070
Quarters > 2 > balance Sheet > property Plant Equipment
323815
Quarters > 2 > balance Sheet > total Assets
20824050
Quarters > 2 > balance Sheet > payables
657128
Quarters > 2 > balance Sheet > short Term Debt
163742
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
3131888
Quarters > 2 > balance Sheet > equity
17692162
Quarters > 2 > cash Flow > net Income
-12098488
Quarters > 2 > cash Flow > depreciation
2641544
Quarters > 2 > cash Flow > change In Working Capital
3932226
Quarters > 2 > cash Flow > cash From Operations
-4241622
Quarters > 2 > cash Flow > capital Expenditures
78568
Quarters > 2 > cash Flow > cash From Investing
-2351402
Quarters > 2 > cash Flow > cash From Financing
3782944
Quarters > 2 > cash Flow > net Change In Cash
-1446233
Quarters > 2 > ratios > PE
-0.08858558405752251
Quarters > 2 > ratios > PB
0.05789597888036521
Quarters > 2 > ratios > ROE
-68.38332138265521
Quarters > 2 > ratios > ROA
-58.09863115004046
Quarters > 2 > ratios > FCF
-4320190
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-9.40832513044766
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2023-09-30
Quarters > 3 > income Statement > revenue
229594
Quarters > 3 > income Statement > cost Of Revenue
2303267
Quarters > 3 > income Statement > gross Profit
-2073673
Quarters > 3 > income Statement > operating Expenses
3675754
Quarters > 3 > income Statement > operating Income
-5462199
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-6049244
Quarters > 3 > income Statement > net Income
-6049244
Quarters > 3 > income Statement > eps
-0.044292792028761255
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
136574005
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-5450058
Quarters > 3 > income Statement > operating Margin
-2379.06870388599
Quarters > 3 > income Statement > total Other Income Expense Net
-299818
Quarters > 3 > balance Sheet > cash
932926
Quarters > 3 > balance Sheet > short Term Investments
1207711
Quarters > 3 > balance Sheet > receivables
99797
Quarters > 3 > balance Sheet > inventories
3320652
Quarters > 3 > balance Sheet > total Current Assets
8560070
Quarters > 3 > balance Sheet > property Plant Equipment
323815
Quarters > 3 > balance Sheet > total Assets
20824050
Quarters > 3 > balance Sheet > payables
657128
Quarters > 3 > balance Sheet > short Term Debt
163742
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3131888
Quarters > 3 > balance Sheet > equity
17692162
Quarters > 3 > cash Flow > net Income
-6049244
Quarters > 3 > cash Flow > depreciation
-35773
Quarters > 3 > cash Flow > change In Working Capital
1966113
Quarters > 3 > cash Flow > cash From Operations
-2120811
Quarters > 3 > cash Flow > capital Expenditures
39284
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
1891472
Quarters > 3 > cash Flow > net Change In Cash
-1446233
Quarters > 3 > ratios > PE
-0.044292792028761255
Quarters > 3 > ratios > PB
0.05789597888036521
Quarters > 3 > ratios > ROE
-34.191660691327606
Quarters > 3 > ratios > ROA
-29.04931557502023
Quarters > 3 > ratios > FCF
-2160095
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-9.40832513044766
Quarters > 3 > health Score
34
Valuation > metrics > PE
-0.04099093471506341
Valuation > metrics > PB
0.06410653938590172
Valuation > final Score
70
Valuation > verdict
93.6% Undervalued
Profitability > metrics > ROE
-35.03715961034852
Profitability > metrics > ROA
-69.15511389565104
Profitability > metrics > Net Margin
-4.8341945580111725
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.15761916751378388
Risk > metrics > Interest Coverage
-11.753052716147122
Risk > final Score
13
Risk > verdict
High
Liquidity > metrics > Current Ratio
3.2531680676075743
Liquidity > metrics > Quick Ratio
2.08947463246266
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
13
Prev Risks > 1
21
Prev Risks > 2
24
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:00:05.804Z
Belluscura plc develops and commercialize oxygen related medical device products in the United States. The company offers X-PLOR and DISCOV-R, a modular portable oxygen concentrator; and related accessories. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAJ Bell Leads The Charge With 2 Other UK Penny Stocks simplywall.st
Read more →AJ Bell (LSE:AJB) Records Market Movement as FTSE 350 Financial Sector Stays Active - Kalkine Media
12/8/2025
AJ Bell (LSE:AJB) Records Market Movement as FTSE 350 Financial Sector Stays Active Kalkine Media
Read more →Showing 2 of 10
(Last Updated 2024-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Belluscura Plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2024-06-30)
(Last Updated 2024-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2024-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2024-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.